Navigation Links
What is the clinical features of primary aortoenteric fistula?
Date:9/24/2008

PAEF is a rare but often life-threatening cause of massive gastrointestinal bleeding. PAEFs have a mortality rate of nearly 100% in the absence of surgical intervention, and in most case, the diagnosis is not established preoperatively. This report presents one such case wherein the cause of death was PAEF-induced massive gastrointestinal bleeding that occurred after discharge of the patient from the hospital. Few previous reports on PAEF provide both the clinical course, including gastrointestinal endoscopic findings, and detailed autopsy findings.

A research team was led by Dr. Ihama address this case and was published on August 7, 2008 in the World Journal of Gastroenterology.

They found that a considerable number of sudden and unexpected deaths have occurred due to PAEFs in cases wherein the diagnosis had not been established. The incidence of PAEF is probably higher than estimated. Moreover, PAEF is a fatal but not an untreatable gastrointestinal disease. However, a PAEF patient cannot be saved without early diagnosis because only an appropriate and urgent surgical invention can rescue the patient. The classical triad of symptoms, i.e., gastrointestinal bleeding, abdominal pain, and a pulsating abdominal mass is probably overemphasized because it occurs in less than 25% of PAEF cases. On the contrary, PAEFs usually present with a herald bleed prior to exsanguination, which is usually minor and self-limiting. If PAEF is diagnosed simultaneously with the herald bleeding, surgical therapy may salvage many patients of PAEF.

Endoscopy is generally the most preferred primary procedure and provides valuable information in cases of gastrointestinal bleeding. In PAEF patients, absence of identifiable bleeding lesions on initial gastrointestinal endoscopy is regarded by clinicians as a strong indicator for laparotomy. However, gastrointestinal endoscopy may be a double-edged sword when PAEFs coexist with multiple bleeding sites. Furthermore, even detection of coexisting bleeding sites by upper endoscopy or colonoscopy, even by capsule endoscopy, may be misleading. Ultimately, the key to early diagnosis of PAEF is endoscopist's heightened index of suspicion; therefore, endoscopists need to recognize PAEF as a potential cause of gastrointestinal bleeding. This article is a valuable step to publicize PAEF.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Related medicine news :

1. Medicare HMO costs may prevent cancer patient clinical trial participation
2. DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance
3. Novel tuberculosis vaccine in Germany in clinical phase
4. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
5. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
6. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
7. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
8. New probe to detect skin cancer receives more funding for clinical trials
9. Prototype test for predicting clinical outcome for melanoma patients
10. Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
11. Clinical Research Management gets contract for trials of therapeutics against infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist ... Throughout the month of February, patients who visit Hamlin Dental Group will receive a ... for two at the Cheesecake Factory. , Tickets are available for routine dental ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... on “Doping in Sport: How the Culture Might Change,” in conjunction ... The symposium will be held at Pepperdine University in Malibu, California. , Sir ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in clinical trials, today announced that Premier Research, a leading clinical development service ... Clinical trials are becoming increasingly complex, due in part to an array of ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism ... Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly ... (ASD) to see films in an environment that accommodates their unique needs. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal ... program today with a new Indiegogo campaign . Individuals are now able ... in the Los Angeles area, either as a participating patient or through an Indiegogo ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , 23. Februar 2017 Im Rahmen ... nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, 2017 mit ... einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. ... Continue Reading ... ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
(Date:2/23/2017)... ... Research and Markets has announced the addition of the "Global ... report to their offering. The Global Antifungal Drugs Market ... next decade to reach approximately $12.8 billion by 2025. ... the given segments on global as well as regional levels presented in ...
Breaking Medicine Technology: